HILL STEPHEN J. (Chief Technical Ops. Officer) sold 6.5% of their position (1.24K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $28.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0001866154-26-000002
Officer· Chief Technical Ops. Officer
Since Jun 2021
-1.24K
Net shares
Net seller
$28.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.24K
Price / share
$23.39
Trade value
$28.91K
% of position
6.5%
2/11/2026
19.03K→17.80K
Total
Net shares
−1.24K
Net value
-$28.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | S · Sale | −1.24K | $23.39 | $28.91K | 6.5% | 19.03K | 17.80K |
| Total | −1.24K | -$28.91K | ||||||
Derivative Transactions0
No derivative transactions reported